Cardiovascular and eletrocardiographic parameters after tonin administration in Wistar rats

Regulatory Peptides

Volumn 181, Issue 1, 2013, Pages 30-36

  Damasceno, Denis D ^a,b   Lima, Mercia P ^b   Motta, Daisy F ^b   Ferreira, Anderson J ^b   Quintão Junior, Judson F ^c   Drummond, Lucas R ^c   Natali, Antônio J ^c   Almeida, Alvair P ^b   Pesquero, Jorge L ^b  

^a Federal Institute of Education Science and Technology of Southeast   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

Autonomic tonus; Electrocardiogram; Isolated heart; Renin angiotensin system; Tonin

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CALCIUM ION; CANDESARTAN; TONIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; CALCIUM; TETRAZOLE DERIVATIVE; TISSUE KALLIKREIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; CORONARY ARTERY PRESSURE; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; HEART FUNCTION; HEART LEFT VENTRICLE DT-DT; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART RATE; HEART RATE VARIABILITY; HEART VENTRICLE; HEART VENTRICLE CONTRACTION; IN VITRO STUDY; IN VIVO STUDY; ISOLATED HEART; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RR INTERVAL; WAKEFULNESS; WISTAR RAT; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; HEART; HEART CONTRACTION; METABOLISM; ORGAN CULTURE TECHNIQUE;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ARTERIAL PRESSURE; BENZIMIDAZOLES; CALCIUM; CELLS, CULTURED; ELECTROCARDIOGRAPHY; HEART; HEART RATE; HEART VENTRICLES; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; ORGAN CULTURE TECHNIQUES; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; TETRAZOLES; TISSUE KALLIKREINS;

MLCS; MLOWN;

EID: 84873431181     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2012.12.009     Document Type: Article

References (42)

1. De Mello W.C. Novel aspects of angiotensin II action in the heart. Implications to myocardial ischemia and heart failure. Regul Pept 2011, 166:9-14.
2. Lavoie J.L., Sigmund C.D. Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 2003, 144:2179-2183.
3. Bader M., Peters J., Baltatu O., Muller D.N., Luft F.C., Ganten D. Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 2001, 79:76-102.
4. Dzau V.J., Ellison K.E., Brody T., Ingelfinger J.R., Pratt R. A comparative study of the distribution of renin and angiotensinogen messenger ribonucleic acids in rat and mouse heart. Endocrinology 1987, 120:2334-2338.
5. Paul M., Mehr A.P., Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 2006, 86:747-803.
6. Boucher R., Demassieux S., Garcia R., Genest J. Tonin, angiotensin II system. A review. Circ Res 1977, 41:26-29.
7. Pesquero J.L., Boschcov P., Oliveira M.C.F., Paiva A.C.M. Effect of substrate size on tonin activity. Biochem Biophys Res Commun 1982, 108:1441-1446.
8. Rosenthal J., Thurnreiter M., Plaschke M., Geyer M., Reiter W., Dahlheim H. Renin-like enzymes in human vasculature. Hypertension 1990, 15:848-853.
9. Grisé C., Boucher R., Thibault G., Genest J. Formation of angiotensin II by tonin from partially purified human angiotensinogen. Can J Biochem 1981, 59:250-255.
10. Araujo G.W., Pesquero J.B., Lindsey C.J., Paiva A.C.M., Pesquero J.L. Identification of serine proteinases with toninlike activity in the rat submandibular and prostate glands. Biochim Biophys Acta 1991, 1074:167-171.
11. Araujo R.C., Lima M.P., Lomez E.S.L., Bader M., Pesquero J.B., Sumitani M., et al. Tonin expression in rat brain and tonin-mediated central production of angiotensin II. Physiol Behav 2002, 76:327-333.
12. Borges J.C., Silva Junior J.A., Gomes M.A., Lomez E.S.L., Araujo R.C., Bader M., et al. Tonin in the rat heart with experimental hypertrophy. Am J Physiol Heart Circ Physiol 2003, 284:H2263-H2268.
13. Schiller P.W., Demassieux S., Boucher R. Substrate specificity of tonin from rat submaxillary gland. Circ Res 1976, 39:629-632.
14. Cardoso C.C., Alenina N., Ferreira A.J., Qadri F., Lima M.P., Gross V., et al. Increased blood pressure and water intake in transgenic mice expressing rat tonin in the brain. Biol Chem 2010, 391:435-441.
15. Almeida A.P., Andrade A.B., Ferreira A.J., Pires A.C.G., Damasceno D.D., Alves M.N.M., et al. Antiarrhythmogenic effects of a neurotoxin from the spider Phoneutria nigriventer. Toxicon 2011, 57:217-224.
16. Bazett H.C. An analysis of the time-relations of electrocardiograms. Heart 1920, 7:353-370.
17. Damasceno D.D., Anderson J.F., Doretto M.C., Almeida A.P. Cardiovascular dysautonomia after seizures induced by maximal electroshock in Wistar rats. Seizure 2012, 21:711-716.
18. Ferreira A.J., Santos R.A.S., Almeida A.P. Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion. Hypertension 2001, 38:665-668.
19. Gualberto M.P., Nunes R.L., Beraldo W.T., Pesquero J.L. Tonin-like activity present in human submandibular gland. Agents Actions Suppl 1992, 38:392-400.
20. Dias-Lopes C., Felicori L., Guimarães G., Gomes E.R.M., Roman-Campos D., Duarte H., et al. Cardiotoxic effects of Loxosceles intermedia spider venom and the recombinant venom toxin rLiD1. Toxicon 2010, 56:1426-1435.
21. Novaes R.D., Penitente A.R., Gonçalves R.V., Talvani A., Neves C.A., Maldonado I.R.S.C., et al. Effects of Trypanosoma cruzi infection on myocardial morphology, single cardiomyocyte contractile function and exercise tolerance in rats. Int J Exp Pathol 2011, 92:299-307.
22. Roman-Campos D., Duarte H.L., Sales P.A., Natali A.J., Ropert C., Gazzinelli R.T., et al. Changes in cellular contractility and cytokines profile during Trypanosoma cruzi infection in mice. Basic Res Cardiol 2009, 104:238-246.
23. Machado B.H., Brody M.J. Contribution of neurogenic mechanisms to control of intrinsic heart rate. Am J Physiol 1989, 256:R231-R235.
24. Lemos M.S., Braga A.N.G., Silva J.R., Santos R.A.S. Altered cardiovascular responses to chronic angiotensin II infusion in aged rats. Regul Pept 2005, 132:67-73.
25. Xu L., Sved A.F. Acute sympathoexcitatory action of angiotensin II in conscious baroreceptor-denervated rats. Am J Physiol Reg Physiol 2002, 283:R451-R459.
26. Lara A., Damasceno D.D., Pires R., Gros R., Gomes E.R., Gavioli M., et al. Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure. Mol Cell Biol 2010, 30:1746-1756.
27. Kawada T., Mizuno M., Shimizu S., Uemura K., Kamiya A., Sugimachi M. Angiotensin II disproportionally attenuates dynamic vagal and sympathetic heart rate controls. Am J Physiol Heart Circ Physiol 2009, 296:H1666-H1674.
28. Akselrod S., Gordon D., Ubel F.A., Shannon D.C., Barger A.C., Cohen R.J. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 1981, 213:220-222.
29. Reid I.A. Interaction between angiotensin II, sympathetic nervous system and baroreceptor reflexes in regulation of blood pressure. Am J Physiol-Endo 1992, 262:E763-E778.
30. Lyons D., Webster J., Benjamin N. Angiotensin II. Adrenergic sympathetic constrictor actions in humans. Circulation 1995, 91:1457-1460.
31. Patil J., Stucki S., Nussberger J., Schaffner T., Gygax S., Bohlender J. Angiotensinergic and noradrenergic neurons in the rat and human heart. Regul Pept 2011, 167:31-41.
32. Merkus D., Haitsma D.B., Sorop O., Boomsma F., De Beer V.J., Lamers J.M.J., et al. Coronary vasoconstrictor influence of angiotensin II is reduced in remodeled myocardium after myocardial infarction. Am J Physiol Heart Circ Physiol 2006, 291:H2082-H2089.
33. Meissner A., Min J.Y., Simon R. Effects of angiotensin II on inotropy and intracellular Ca2+ handling in normal and hypertrophied rat myocardium. J Mol Cell Cardiol 1998, 30:2507-2518.
34. Li P., Sonnenblick E.H., Anversa P., Capasso J.M. Length-dependent modulation of ANG II inotropism in rat myocardium: effects of myocardial infarction. Am J Physiol Heart Circ Physiol 1994, 266:H779-H786.
35. Palomeque J., Sapia L., Hajjar R.J., Mattiazzi A., Petroff M.V. Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK. Am J Physiol Heart Circ Physiol 2006, 290:H96-H106.
36. Downey J.M. Myocardial contractile force as a function of coronary blood flow. Am J Physiol-Legacy Content 1976, 230:1-6.
37. Schulz R., Heusch G. The relationship between regional blood flow and contractile function in normal, ischemic, and reperfused myocardium. Basic Res Cardiol 1998, 93:455-462.
38. Morita H., Tsojioka K., Kimura A., Ogasawara Y., Goto O., Hiramatsu O., et al. ?-Adrenergic vasoconstriction reduces systolic retrograde coronary blood flow. Am J Physiol Heart Circ Physiol 1997, 273:H2746-H2755.
39. Andersson O.K., Neldam S. The antihypertensive effect and tolerability of candesartan cilexetil, a new generation angiotensin II antagonist, in comparison with losartan. Blood Press 1998, 7:251-252.
40. Lindpaintner K., Jin M.W., Niedermaier N., Wilhelm M.J., Ganten D. Cardiac angiotensinogen and its local activation in the isolated perfused beating heart. Circ Res 1990, 67:564-573.
41. Bers D.M. Altered cardiac myocyte Ca regulation in heart failure. Physiology 2006, 21:380-387.
42. Bers D.M. Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol 2008, 70:23-49.